Filing Details

Accession Number:
0001213900-16-012631
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-18 17:24:45
Reporting Period:
2016-04-14
Filing Date:
2016-04-18
Accepted Time:
2016-04-18 17:24:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388320 Actinium Pharmaceuticals Inc. ATNM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1293789 I Richard Steinhart C/O Actinium Pharmaceuticals, Inc
275 Madison Avenue, 7Th Floor
New York NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-14 2,500 $2.01 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Acquisiton 2016-04-15 75,000 $1.99 75,000 $1.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,000 2026-04-15 No 4 A Direct
Footnotes
  1. Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.